These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23678130)

  • 1. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease.
    Barron AM; Garcia-Segura LM; Caruso D; Jayaraman A; Lee JW; Melcangi RC; Pike CJ
    J Neurosci; 2013 May; 33(20):8891-7. PubMed ID: 23678130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSPO ligand PK11195 improves Alzheimer-related outcomes in aged female 3xTg-AD mice.
    Christensen A; Pike CJ
    Neurosci Lett; 2018 Sep; 683():7-12. PubMed ID: 29925037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease.
    Pradhan AK; Neumüller T; Klug C; Fuchs S; Schlegel M; Ballmann M; Tartler KJ; Pianos A; Garcia MS; Liere P; Schumacher M; Kreuzer M; Rupprecht R; Rammes G
    Transl Psychiatry; 2023 Oct; 13(1):332. PubMed ID: 37891168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration.
    Ma L; Zhang H; Liu N; Wang PQ; Guo WZ; Fu Q; Jiao LB; Ma YQ; Mi WD
    Brain Res Bull; 2016 Mar; 121():192-200. PubMed ID: 26851069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator protein (TSPO) ligands attenuate mitophagy deficits in the SH-SY5Y cellular model of Alzheimer's disease via the autophagy adaptor P62.
    Fairley LH; Grimm A; Herff SA; Eckert A
    Biochimie; 2024 Sep; 224():132-138. PubMed ID: 38280505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice.
    Roberts JC; Friel SL; Roman S; Perren M; Harper A; Davis JB; Richardson JC; Virley D; Medhurst AD
    Exp Neurol; 2009 Apr; 216(2):459-70. PubMed ID: 19320004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.
    Knight EM; Brown TM; Gümüsgöz S; Smith JC; Waters EJ; Allan SM; Lawrence CB
    Dis Model Mech; 2013 Jan; 6(1):160-70. PubMed ID: 22864021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
    Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
    Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.
    Fairley LH; Sahara N; Aoki I; Ji B; Suhara T; Higuchi M; Barron AM
    J Neuroinflammation; 2021 Mar; 18(1):76. PubMed ID: 33740987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer's disease.
    Tournier BB; Tsartsalis S; Rigaud D; Fossey C; Cailly T; Fabis F; Pham T; Grégoire MC; Kövari E; Moulin-Sallanon M; Savioz A; Millet P
    Neurobiol Dis; 2019 Jan; 121():95-105. PubMed ID: 30261283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK
    J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.